These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30599150)

  • 1. Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
    Boitard SE; Marc Y; Keck M; Mougenot N; Agbulut O; Balavoine F; Llorens-Cortes C
    J Mol Cell Cardiol; 2019 Feb; 127():215-222. PubMed ID: 30599150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction.
    Leenen FHH; Ahmad M; Marc Y; Llorens-Cortes C
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):82-91. PubMed ID: 30531435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction.
    Boitard SE; Keck M; Deloux R; Girault-Sotias PE; Marc Y; De Mota N; Compere D; Agbulut O; Balavoine F; Llorens-Cortes C
    Can J Cardiol; 2022 Jun; 38(6):815-827. PubMed ID: 35091008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.
    Marc Y; Boitard SE; Balavoine F; Azizi M; Llorens-Cortes C
    Can J Cardiol; 2020 May; 36(5):721-731. PubMed ID: 32389345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction.
    Huang BS; Ahmad M; White RA; Marc Y; Llorens-Cortes C; Leenen FH
    Cardiovasc Res; 2013 Mar; 97(3):424-31. PubMed ID: 23257024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
    Hmazzou R; Marc Y; Flahault A; Gerbier R; De Mota N; Llorens-Cortes C
    Clin Sci (Lond); 2021 Mar; 135(6):775-791. PubMed ID: 33683322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
    Marc Y; Hmazzou R; De Mota N; Balavoine F; Llorens-Cortes C
    Biomed Pharmacother; 2021 Aug; 140():111682. PubMed ID: 34020248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats.
    Marc Y; Gao J; Balavoine F; Michaud A; Roques BP; Llorens-Cortes C
    Hypertension; 2012 Aug; 60(2):411-8. PubMed ID: 22710644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.
    Ferdinand KC; Balavoine F; Besse B; Black HR; Desbrandes S; Dittrich HC; Nesbitt SD
    Circulation; 2019 Jul; 140(2):138-146. PubMed ID: 31014072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future Directions.
    Keck M; Hmazzou R; Llorens-Cortes C
    Curr Hypertens Rep; 2019 May; 21(7):50. PubMed ID: 31115779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
    Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
    Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.
    Alghamri MS; Morris M; Meszaros JG; Elased KM; Grobe N
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1032-40. PubMed ID: 24464749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction.
    González GE; Wilensky L; Cassaglia P; Morales C; Gelpi RJ
    Cardiovasc Pathol; 2016; 25(3):208-213. PubMed ID: 26897484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.
    Fournie-Zaluski MC; Fassot C; Valentin B; Djordjijevic D; Reaux-Le Goazigo A; Corvol P; Roques BP; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7775-80. PubMed ID: 15136730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
    Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
    Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade.
    Huang BS; Ahmad M; Tan J; Leenen FH
    J Mol Cell Cardiol; 2007 Oct; 43(4):479-86. PubMed ID: 17714732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Pro)renin Receptor Blockade Ameliorates Cardiac Injury and Remodeling and Improves Function After Myocardial Infarction.
    Ellmers LJ; Rademaker MT; Charles CJ; Yandle TG; Richards AM
    J Card Fail; 2016 Jan; 22(1):64-72. PubMed ID: 26362519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension.
    Keck M; De Almeida H; Compère D; Inguimbert N; Flahault A; Balavoine F; Roques B; Llorens-Cortes C
    Hypertension; 2019 Jun; 73(6):1300-1307. PubMed ID: 31067198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.